Assessment of the optimal time interval and background region of interest in the measurement of differential renal function in Tc-99m-EC renography

Annals of Nuclear Medicine

Volumn 18, Issue 5, 2004, Pages 419-425

  Yapar, A Fuat ^a   Aydin, Mehmet ^a   Reyhan, Mehmet ^a   Yapar, Zeynep ^b   Yologlu, Nazli Altun ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Differential renal function; Renal scintigraphy; Tc 99m EC

Indexed keywords

ETHYLENE DICYSTEINE TC 99M; SUCCIMER TC 99M; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL RENAL FUNCTION; DRUG UPTAKE; FEMALE; HUMAN; INFANT; KIDNEY FUNCTION; MALE; MATHEMATICAL MODEL; OPTIMAL TIME INTERVAL; PRIORITY JOURNAL; RADIOBIOLOGY; REGION OF INTEREST; RENOGRAPHY; REPRODUCIBILITY; STATISTICAL ANALYSIS; TIME;

EID: 4644320666     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984485     Document Type: Article

References (28)

1. Van Nerom CG, Bormans GM, De Roo MJ, Verbruggen AM. First experience in healthy volunteers with technetium-99m-L,L-ethylenedicysteine, a new renal imaging agent. Eur J Nucl Med 1993; 20: 738-746.
2. Kabasakal L, Turoglu HT, Onsel C, Ozker K, Uslu I, Atay S, et al. Clinical comparision of Technetium-99m-EC, Technetium-99m-MAG3 and Iodine-131-OIH in renal disorders. J Nucl Med 1995; 36: 224-228.
3. Kabasakal L, Atay S, Vural AV, Ozker K, Sonmezoglu K, Demir M, et al. Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio. J Nucl Med 1995; 36: 1398-1403.
4. Nielsen SS, Poulsen EU, Markversen J, Nielsen LE, Bacher T, Rehling M. Clearance and renal extraction of technetium-99m-L,L-ethylenedicysteine, I-131-orthoiodohippurate and I-125-iothalamate in pigs. Clin Physiol 1999; 19: 338-343.
5. Taylor A Jr, Nally JV. Clinical applications of renal scintigraphy. Am J Roentgenol 1995; 164: 31-41.
6. Oei HY. Dynamic and static renal imaging. In Nuclear Medicine in Clinical Diagnosis and Treatment, Murray IPC, Ell PJ (eds) 1st ed. New York; Churchill Livingstone, Inc., 1994: 213-227.
7. 99mTc-DTPA renography. Nucl Med Commun 1988; 9: 973-985.
8. Taylor A Jr, Thakore K, Folks R, Halkar R, Manatunga A. Background subtraction in technetium-99m-MAG3 renography. J Nucl Med 1997; 38: 74-79.
9. Taylor A, Lewis C, Giacometti A, Hall EC, Barefield KP. Improved formulas for the estimation of renal depth in adults. J Nucl Med 1993; 34: 1766-1769.
10. Lythgoe MF, Gradwell MJ, Evans K, Gordon I. Estimation and relevance of depth correction in paediatric renal studies. Eur J Nucl Med 1998; 25: 115-119.
11. 99mTc-MAG3 renal uptake: Reproducibility and accuracy. J Nucl Med 1999; 40: 972-976.
12. Tamminen TE, Riihimaki EJ, Tahti EE. A gamma camera method for quantitation of split renal function in children followed for vesicoureteric reflux. Pediatr Radiol 1978; 7: 78-81.
13. Makler PT, Charkes NN, Malmud LS. Calculation of net renal uptake curves without use of a blood pool agent. Eur J Nucl Med 1979; 4: 339-342.
14. 99mTc-DTPA dynamic renal scan with deconvolution analysis. J Nucl Med 1976; 17: 352-355.
15. 99mTc-DTPA complex and a scintillation camera. Eur J Nucl Med 1977; 2: 173-177.
16. 99mTc-DTPA and the gamma camera: a comparison of methods. Eur J Nucl Med 1985; 10: 519-521.
17. Gordon I, Colarinha P, Fettich J, Fischer S, Frokier J, Hahn K, et al. Guidelines for standard and diuretic renography in children. Eur J Nucl Med 2001; 28: BP21-30.
18. Fleming JS. Measurement of hippuran plasma clearance using a gamma camera. Phys Med Biol 1977; 22: 526-530.
19. Gates GF. Split renal function testing using Tc-99m DTPA. A rapid technique for determining differential glomerular filtration. Clin Nucl Med 1983; 8: 400-407.
20. 99mTc-DTPA (stannous). Am J Roentgenol 1982; 138: 565-570.
21. Tondeur M, Piepsz A, Dobbeleir A, Ham H. Technetium 99m mercaptoacetyltriglycine gamma camera clearance calculations: methodological problems. Eur J Nucl Med 1991; 18: 83-86.
22. 99mTc-MAG3 renography without blood sampling. J Nucl Med 1999; 40: 793-798.
23. Kibar M, Noyan A, Anarat A. Tc-99m-N,N-ethylenedicysteine scintigraphy in children with various renal disorders: a comparative study with Tc-99m-MAG3. Nucl Med Commun 1997; 18: 44-52.
24. Ozker K, Onsel C, Kabasakal L, Sayman HB, Uslu I, Bozluolcay S, et al. Technetium-99m-N,N-ethylenedicysteine-a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease. J Nucl Med 1994; 35: 840-845.
25. Kibar M, Yapar Z, Noyan A, Anarat A. Technetium-99m-N,N- ethylenedicysteine and Tc-99m DMSA scintigraphy in the evaluation of renal parenchymal abnormalities in children. Ann Nucl Med 2003; 17: 219-225.
26. Gupta NK, Bomanji JB, Waddington W, Lui D, Costa DC, Verbruggen AM, et al. Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders. Eur J Nucl Med 1995; 22: 617-624.
27. Piepsz A, Blaufox MD, Gordon I, Granerus G, Majd M, O'Reilly P, et al. Consensus on renal cortical scintigraphy in children with urinary tract infection. Semin Nucl Med 1999; 29: 160-174.
28. m-DMSA. Br J Radiol 1987; 60: 869-872.